06.06.2019 • News

Nouryon Announces New Structure

Nouryon is to expand monochloroacetic acid (MCA) production capacity at its...
Nouryon is to expand monochloroacetic acid (MCA) production capacity at its size in Delfzijl, the Netherlands, by the end of 2020. The extra output will meet market growth as well as satisfy Nouryon’s own increased consumption of MCA to produce carboxymethyl cellulose. © Nouryon

Dutch specialty chemicals company Nouryon has announced a new organizational model as part of its strategy to accelerate growth and drive performance improvement. The new model, which will take effect Jan. 1, 2020, is organized around three market-focused businesses supported by a centralized operations and functional structure, the company said.

The three businesses are Technology Solutions, which will be headed by Johan Landfors; Industry Chemicals, where Knut Schwalenberg will continue as president; and Performance Formulations, with a president to be named at a later date.

Lanny Duvall will continue as Chief Integrated Supply Chain Officer.

“This optimized model will allow our Businesses and support organizations to concentrate on what they do best,” said Charlie Shaver, Nouryon CEO. “Each Business will have a clear mission, driving management focus.”

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read